Sign in
4

Changes in Ownership

Zenas BioPharma, Inc. Filed Acc 0001104659-24-101030

10% owner acquired 801,624 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Wellington Biomedical Innovation Master Investors (Cayman) I L.P. · 10% owner

Table I: Non-derivative

3 lines
Date Transaction Shares Owned after D/I
2024-09-16 Conversion : show line 1 in the form +180,635 180,635 D
2024-09-16 Conversion : show line 2 in the form +420,271 600,906 D
2024-09-16 Conversion : show line 3 in the form +200,718 801,624 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-09-16 Conversion : show line 4 in the form Series A Convertible Preferred Stock −1,568,480 0 D
2024-09-16 Conversion : show line 5 in the form Series B Convertible Preferred Stock −3,649,263 0 D
2024-09-16 Conversion : show line 6 in the form Series C Convertible Preferred Stock −1,742,858 0 D
Loading xslF345X05/tm2424157-11_4seq1.xml…